{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:53:50Z","timestamp":1772121230596,"version":"3.50.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.mehy.2020.110208","type":"journal-article","created":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T11:31:59Z","timestamp":1598268719000},"page":"110208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Repurposing prolactin as a promising immunomodulator for the treatment of COVID-19: Are common Antiemetics the wonder drug to fight coronavirus?"],"prefix":"10.1016","volume":"144","author":[{"given":"Amarnath","family":"Sen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.mehy.2020.110208_b0005","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s11684-020-0767-8","article-title":"Coronavirus disease 2019 (COVID-19): A clinical update","volume":"14","author":"Zhou","year":"2020","journal-title":"Front Med"},{"issue":"4","key":"10.1016\/j.mehy.2020.110208_b0010","first-page":"1","article-title":"Coronavirus disease 2019 treatment: A review of early and emerging options","volume":"7","author":"McCreary","year":"2020","journal-title":"Open Forum Infectious Dis"},{"issue":"18","key":"10.1016\/j.mehy.2020.110208_b0015","first-page":"1824","article-title":"Pharmacologic treatments for coronavirus disease 2019 (COVID-19)-A review","volume":"323","author":"Sanders","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.mehy.2020.110208_b0020","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.3390\/ijms21093330","article-title":"Cytokine release syndrome in COVID-19 patients, a new scenario for an old concern: The fragile balance between infections and autoimmunity","volume":"21","author":"Diamanti","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.mehy.2020.110208_b0025","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ijid.2020.04.041","article-title":"Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019","volume":"95","author":"Zhu","year":"2020","journal-title":"Int J Infectious Dis"},{"issue":"1758","key":"10.1016\/j.mehy.2020.110208_b0030","article-title":"COVID-19-associated hyperviscosity: a link between inflammation and thrombophilia?","volume":"95","author":"Maier","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2020.110208_b0035","doi-asserted-by":"crossref","unstructured":"Magro G, SARS-CoV-2 and COVID-19: Is interleukin-6 (IL-6) the \u2018culprit lesion\u2019 of ARDS onset? What is there besides Tocilizumab? SGP130Fc. Cytokine. 2020; X 2:100029, https:\/\/doi.org\/10.1016\/j.cytox.2020.100029.","DOI":"10.1016\/j.cytox.2020.100029"},{"key":"10.1016\/j.mehy.2020.110208_b0040","doi-asserted-by":"crossref","first-page":"Article 82","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.mehy.2020.110208_b0045","doi-asserted-by":"crossref","first-page":"7639","DOI":"10.18632\/aging.103101","article-title":"Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2","volume":"12","author":"Yao","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.mehy.2020.110208_b0050","article-title":"The immunology of COVID-19: Is immune modulation an option for treatment?","volume":"May20","author":"Zhong","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.mehy.2020.110208_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106455","article-title":"The possible of immunotherapy for COVID-19: a systematic review","volume":"83","author":"AminJafari","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.mehy.2020.110208_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(20)30217-4","article-title":"Immunotherapies for COVID-19: Lessons learned from sepsis","author":"Remy","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.mehy.2020.110208_b0065","article-title":"COVID-19: Immunology and treatment options","volume":"215","author":"Felsensteina","year":"2020","journal-title":"Clinical Immunol"},{"key":"10.1016\/j.mehy.2020.110208_b0070","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00749-2020","article-title":"Will children reveal their secret? The coronavirus dilemma","author":"Cristiani","year":"2020","journal-title":"Eur Respir J."},{"key":"10.1016\/j.mehy.2020.110208_b0075","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202048693","article-title":"Prevention and treatment of COVID-19 disease by controlled modulation of innate immunity","author":"Schijns","year":"2020","journal-title":"Eur J Immunology"},{"key":"10.1016\/j.mehy.2020.110208_b0080","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140530","article-title":"Is innate immunity our best weapon for flattening the curve?","author":"Angka","year":"2020","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.mehy.2020.110208_b0085","first-page":"313","article-title":"Role of prolactin in the immune response","volume":"69","author":"Blanco-Favela","year":"2012","journal-title":"Bolet\u00edn m\u00e9dico del Hospital Infantil de M\u00e9xico"},{"key":"10.1016\/j.mehy.2020.110208_b0090","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11102-005-5082-5","article-title":"Prolactin and autoimmunity","volume":"8","author":"De Bellis","year":"2005","journal-title":"Pituitary"},{"key":"10.1016\/j.mehy.2020.110208_b0095","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3181\/00379727-215-44111","article-title":"Molecular actions of prolactin in the immune system","volume":"2151","author":"Yu-Lee","year":"1997","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.mehy.2020.110208_b0100","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fimmu.2018.00073","article-title":"Prolactin and autoimmunity","volume":"9","author":"Borba","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.mehy.2020.110208_b0105","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-3-319-12114-7_11","article-title":"Prolactin in inflammatory response","volume":"846","author":"Pereira-Suarez","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.mehy.2020.110208_b0110","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/416739","article-title":"Changes in the Th1: Th2 cytokine bias in pregnancy and the effects of the anti-inflammatory cyclopentenone prostaglandin 15-deoxy-\u039412,14-prostaglandin J2","volume":"2012","author":"Sykes","year":"2012","journal-title":"Mediators Inflamm"},{"issue":"2","key":"10.1016\/j.mehy.2020.110208_b0115","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1179\/102453312X13221316477930","article-title":"Moderate hyperprolactinemia is associated with survival in patients with acute graft-versus-host disease after allogeneic stem cell transplantation","volume":"17","author":"Parra","year":"2012","journal-title":"Hematology"},{"key":"10.1016\/j.mehy.2020.110208_b0120","first-page":"1303","author":"Fuhrman","year":"2011","journal-title":"Paediatric Critical Care"},{"key":"10.1016\/j.mehy.2020.110208_b0125","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1210\/rp.57.1.435","article-title":"Prolactin modulation of immune and inflammatory responses","volume":"57","author":"Yu-Lee","year":"2002","journal-title":"Recent Prog Horm Res"},{"key":"10.1016\/j.mehy.2020.110208_b0130","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1043-4666(02)00496-9","article-title":"Prolactin enhances production of interferon-gamma, interleukin-12, and interleukin-10, but not of tumor necrosis factor-alpha, in a stimulus-specific manner","volume":"21","author":"Matalka","year":"2003","journal-title":"Cytokine"},{"issue":"Suppl 1","key":"10.1016\/j.mehy.2020.110208_b0135","first-page":"255","article-title":"Prolactin and autoimmune diseases in humans","volume":"78","author":"Chuang","year":"2007","journal-title":"Acta Biomed"},{"issue":"9","key":"10.1016\/j.mehy.2020.110208_b0140","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1172\/JCI69485","article-title":"Prolactin promotes cartilage survival and attenuates inflammation in inflammatory arthritis","volume":"123","author":"Ad\u00e1n","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2020.110208_b0145","first-page":"95","article-title":"The role of neuroendocrine system in the pathogenesis of rheumatic disease (minireview)","volume":"36","author":"Imrich","year":"2002","journal-title":"Endocrine Regulations"},{"issue":"6\u20137","key":"10.1016\/j.mehy.2020.110208_b0150","first-page":"A465","article-title":"Prolactin and autoimmunity","volume":"11","author":"Shelly","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.mehy.2020.110208_b0155","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41419-017-0151-z","article-title":"Prolactin inhibits the progression of intervertebral disc degeneration through inactivation of the NF-\u03baB pathway in rats","volume":"9","author":"Wu","year":"2018","journal-title":"Cell Death Dis"},{"issue":"9","key":"10.1016\/j.mehy.2020.110208_b0160","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1136\/adc.65.9.977","article-title":"Plasma prolactin and clinical outcome in preterm infants","volume":"65","author":"Lucas","year":"1990","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.mehy.2020.110208_b0165","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00005373-199801000-00006","article-title":"Metoclopramide: a novel and safe immunomodulating agent for restoring the depressed macrophage immune function after hemorrhage","volume":"44","author":"Zellweger","year":"1998","journal-title":"J Trauma"},{"issue":"3","key":"10.1016\/j.mehy.2020.110208_b0170","first-page":"207","article-title":"Imipramine induced elevation of prolactin levels in patients with HIV\/AIDS improved their immune status","volume":"58","author":"Orlander","year":"2009","journal-title":"West Indian Med J"},{"issue":"1","key":"10.1016\/j.mehy.2020.110208_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/NIB-130050","article-title":"A Th1-type cytokine named prolactin: facts and hypotheses","volume":"4","author":"Parra","year":"2013","journal-title":"Adv Neuroimmune Biol"},{"key":"10.1016\/j.mehy.2020.110208_b0180","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.lfs.2016.03.027","article-title":"Attenuated allergic inflammatory response in the lungs during lactation","volume":"151","author":"Ochoa-Amaya","year":"2016","journal-title":"Life Sci"},{"key":"10.1016\/j.mehy.2020.110208_b0185","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.lfs.2015.10.016","article-title":"Short-term hyperprolactinemia decreases allergic inflammatory response of the lungs","volume":"142","author":"Ochoa-Amaya","year":"2015","journal-title":"Life Sci"},{"issue":"3","key":"10.1016\/j.mehy.2020.110208_b0190","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4103\/0974-1208.121400","article-title":"Hyperprolactinemia","volume":"6","author":"Majumdar","year":"2013","journal-title":"J Hum Reprod Sci"},{"issue":"8","key":"10.1016\/j.mehy.2020.110208_b0195","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.4065\/80.8.1050","article-title":"Medication-induced hyperprolactinemia","volume":"80","author":"Molitch","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.mehy.2020.110208_b0200","first-page":"175","article-title":"Effects of prolactin on innate immunity of infectious diseases","volume":"3","author":"L\u00f3pez-Meza","year":"2010","journal-title":"Open Neuroendocrinol J"},{"key":"10.1016\/j.mehy.2020.110208_b0205","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s10695-015-0155-5","article-title":"Immunostimulatory effect of salmon prolactin on expression of Toll-like receptors in Oncorhynchus mykiss infected with Piscirickettsia salmonis","volume":"42","author":"Pe\u00f1a","year":"2016","journal-title":"Fish Physiol Biochem"},{"issue":"5","key":"10.1016\/j.mehy.2020.110208_b0210","doi-asserted-by":"crossref","first-page":"481","DOI":"10.33549\/physiolres.932262","article-title":"Monitoring of the course of sepsis in hematooncological patients by extrapituitary prolactin expression in peripheral blood monocytes","volume":"61","author":"Cejkova","year":"2012","journal-title":"Physiol Res"},{"key":"10.1016\/j.mehy.2020.110208_b0215","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.4049\/jimmunol.174.6.3765","article-title":"Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple organ failure","volume":"174","author":"Felmet","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2020.110208_b0220","first-page":"1","article-title":"Gender differences in patients with COVID-19: focus on severity and mortality","volume":"29","author":"Jin","year":"2020","journal-title":"Front Public Health"},{"issue":"4","key":"10.1016\/j.mehy.2020.110208_b0225","doi-asserted-by":"crossref","first-page":"M131","DOI":"10.1093\/geronj\/44.4.M131","article-title":"Serum prolactin and aging: Basal values and changes with estrogen use and hypothyroidism","volume":"44","author":"Sawin","year":"1989","journal-title":"J Gerontol"},{"key":"10.1016\/j.mehy.2020.110208_b0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2214\/AJR.20.23072","article-title":"Pregnancy and perinatal outcomes of women with coronavirus disease (COVID-19) pneumonia: preliminary analysis","volume":"215","author":"Liu","year":"2020","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.mehy.2020.110208_b0235","doi-asserted-by":"crossref","DOI":"10.1002\/oby.22843","article-title":"Is adipose tissue a reservoir for viral spread, immune activation, and cytokine amplification in coronavirus disease 2019?","author":"Ryan","year":"2020","journal-title":"Obesity"},{"issue":"Suppl 2","key":"10.1016\/j.mehy.2020.110208_b0240","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1038\/sj.ijo.0801291","article-title":"Physiopathology of prolactin secretion in obesity","volume":"24","author":"Kopelman","year":"2000","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.mehy.2020.110208_b0245","doi-asserted-by":"crossref","unstructured":"Gonzalez-Rubio J, Navarro-Lopez C, Lopez-Najera E, Opez-Najera A, Jimenez-Diaz L, Navarro-Lopez JD, Najera A. What is happening with smokers and COVID-19? A systematic review and a meta-analysis. 2020; doi:10.20944\/preprints202004. 0540.v1.","DOI":"10.20944\/preprints202004.0540.v1"},{"key":"10.1016\/j.mehy.2020.110208_b0250","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF00433730","article-title":"Nicotine from cigarette smoking increases circulating levels of cortisol, growth hormone, and prolactin in male chronic smokers","volume":"78","author":"Wilkins","year":"1982","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.mehy.2020.110208_b0255","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.encep.2020.05.006","article-title":"Repurposing chlorpromazine to treat COVID-19: The reCoVery study","volume":"46","author":"Plaze","year":"2020","journal-title":"L'Enc\u00e9phale"},{"issue":"5","key":"10.1016\/j.mehy.2020.110208_b0260","first-page":"929","article-title":"Pharmacological causes of hyperprolactinemia","volume":"3","author":"Torre","year":"2007","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.mehy.2020.110208_b0265","doi-asserted-by":"crossref","unstructured":"Freedberg DE, Conigliaro J, Magdalena J, Sobieszczyk E, Markowitz DD, Gupta A, et al. Famotidine use is associated with improved clinical outcomes in hospitalized COVID-19 patients: A propensity score matched retrospective cohort study. 2020; May 19, medRxiv preprint doi: https:\/\/doi.org\/10.1101\/2020.05.01.20086694.","DOI":"10.1053\/j.gastro.2020.05.053"},{"key":"10.1016\/j.mehy.2020.110208_b0270","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1203\/00006450-197305000-00007","article-title":"Serum prolactin levels in humans from birth to adult life","volume":"7","author":"Guyda","year":"1973","journal-title":"Pediat Res"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2020.110208_b0275","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cellimm.2007.12.003","article-title":"Neuroendocrine hormones such as growth hormone and prolactin are integral members of the immunological cytokine network","volume":"252","author":"Redelman","year":"2008","journal-title":"Cell Immunol"},{"key":"10.1016\/j.mehy.2020.110208_b0280","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.4049\/jimmunol.148.12.3799","article-title":"Immunologic and hematologic effects of neuroendocrine hormones, studies on DW\/J dwarf mice","volume":"48","author":"Murphy","year":"1992","journal-title":"J Immunol"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720320144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720320144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:32:57Z","timestamp":1759692777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987720320144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":56,"alternative-id":["S0306987720320144"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2020.110208","relation":{"has-preprint":[{"id-type":"doi","id":"10.31219\/osf.io\/ch2sa","asserted-by":"object"}]},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing prolactin as a promising immunomodulator for the treatment of COVID-19: Are common Antiemetics the wonder drug to fight coronavirus?","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2020.110208","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110208"}}